Skip to main content
. 2021 Sep 18;10(9):2220. doi: 10.3390/foods10092220

Figure 4.

Figure 4

Bioactive peptides exhibit antidiabetic effects for type 2 diabetes mellitus based on inhibition against α- amylase, α-glucosidase, sodium glucose co-transporter-2 inhibitors, plasma-based dipeptidyl peptidase-4 (DPP4) inhibitors (an obesity-independent parameter for glycaemic deregulation in type 2 diabetes patients), and insulin mimetic (which promote the glucose entry into the tissues, whereas the glucose either be converted into energy or stored for later use), respectively.